Giuseppe Bruno
Giuseppe Bruno
Email verificata su
Citata da
Citata da
A refinement of the benzoic acid structure at room temperature
G Bruno, L Randaccio
Acta Crystallographica Section B: Structural Crystallography and Crystalá…, 1980
A case-control study on Alzheimer’s disease and exposure to anesthesia
M Gasparini, N Vanacore, C Schiaffini, L Brusa, M Panella, G Talarico, ...
Neurological Sciences 23 (1), 11-14, 2002
The GERAS study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries–study design andá…
A Wimo, CC Reed, R Dodel, M Belger, RW Jones, M Happich, ...
Journal of Alzheimer's Disease 36 (2), 385-399, 2013
Muscarinic agonist therapy of Alzheimer's disease: a clinical trial of RS-86
G Bruno, E Mohr, M Gillespie, P Fedio, TN Chase
Archives of neurology 43 (7), 659-661, 1986
Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging
SA Lightle, JI Oakley, MN Nikolova-Karakashian
Mechanisms of ageing and development 120 (1-3), 111-125, 2000
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation
D Galimberti, C Fenoglio, M Serpente, C Villa, R Bonsi, A Arighi, ...
Biological psychiatry 74 (5), 384-391, 2013
Caregiver burden in Alzheimer's disease: differential associations in adult-child and spousal caregivers in the GERAS observational study
C Reed, M Belger, G Dell'Agnello, A Wimo, JM Argimon, G Bruno, ...
Dementia and geriatric cognitive disorders extra 4 (1), 51-64, 2014
New strategies in the management of Parkinson’s disease: a biological approach using a phospholipid precursor (CDP-choline)
A Agnoli, S Ruggieri, A Denaro, G Bruno
Neuropsychobiology 8 (6), 289-296, 1982
Analysis of burden in caregivers of people with Alzheimer’s disease using self-report and supervision hours
JM Haro, K Kahle-Wrobleski, G Bruno, M Belger, G Dell’Agnello, R Dodel, ...
The journal of nutrition, health & aging 18 (7), 677-684, 2014
Friction stir welding of polyethylene sheets
EA Squeo, G Bruno, A Guglielmotti, F Quadrini
The Annals of DUNANjREA DE JOS University of Galati Fascicle V. Technologiesá…, 2009
Buspirone, Parkinson's disease, and the locus ceruleus
CL Ludwig, DR Weinberger, G Bruno, M Gillespie, K Bakker, PA LeWitt, ...
Clinical neuropharmacology 9 (4), 373-378, 1986
Ganzfeld electroretinographic findings in parkinsonism: untreated patients and the effect of levodopa intravenous infusion.
MJ Jaffe, G Bruno, G Campbell, RA Lavine, CN Karson, DR Weinberger
Journal of Neurology, Neurosurgery & Psychiatry 50 (7), 847-852, 1987
Spontaneous reversion of mild cognitive impairment to normal cognition: a systematic review of literature and meta-analysis
M Canevelli, G Grande, E Lacorte, E Quarchioni, M Cesari, C Mariani, ...
Journal of the American Medical Directors Association 17 (10), 943-948, 2016
Behavioral and psychological subsyndromes in Alzheimer's disease using the Neuropsychiatric Inventory
M Canevelli, N Adali, T Voisin, ME Soto, G Bruno, M Cesari, B Vellas
International Journal of Geriatric Psychiatry 28 (8), 795-803, 2013
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease
P Barbanti, G Fabbrini, A Ricci, G Bruno, R Cerbo, E Bronzetti, F Amenta, ...
Mechanisms of ageing and development 120 (1-3), 65-75, 2000
Relation of EEG alpha background to parietal lobe function in Alzheimer's disease as measured by positron emission tomography and psychometry
PH Sheridan, S Sato, N Foster, G Bruno, C Cox, P Fedio, TN Chase
Neurology 38 (5), 747-747, 1988
GABA-agonist therapy for Alzheimer's disease.
E Mohr, G Bruno, N Foster, M Gillespie, C Cox, TA Hare, C Tamminga, ...
Clinical neuropharmacology 9 (3), 257-263, 1986
Determinants of societal costs in Alzheimer's disease: GERAS study baseline results
R Dodel, M Belger, C Reed, A Wimo, RW Jones, M Happich, JM Argimon, ...
Alzheimer's & Dementia 11 (8), 933-945, 2015
Diosmin binding to human serum albumin and its preventive action against degradation due to oxidative injuries
D Barreca, G LaganÓ, G Bruno, S Magaz¨, E Bellocco
Biochimie 95 (11), 2042-2049, 2013
Acetyl-L-carnitine in Alzheimer disease: a short-term study on CSF neurotransmitters and neuropeptides
G Bruno, S Scaccianoce, M Bonamini, FR Patacchioli, F Cesarino, ...
Alzheimer Disease & Associated Disorders 9 (3), 128-131, 1995
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20